192 related articles for article (PubMed ID: 9544973)
1. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura.
Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL
Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973
[TBL] [Abstract][Full Text] [Related]
2. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
Moore JC; Murphy WG; Kelton JG
Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
4. Increased von Willebrand factor (vWf) binding to platelets associated with impaired vWf breakdown in thrombotic thrombocytopenic purpura.
Moake JL; Chow TW
J Clin Apher; 1998; 13(3):126-32. PubMed ID: 9828023
[TBL] [Abstract][Full Text] [Related]
5. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
[TBL] [Abstract][Full Text] [Related]
6. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
Kelton JG; Moore JC; Murphy WG
Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons.
Feys HB; Roodt J; Vandeputte N; Pareyn I; Mottl H; Hou S; Lamprecht S; Van Rensburg WJ; Deckmyn H; Vanhoorelbeke K
Blood; 2012 Oct; 120(17):3611-4. PubMed ID: 22855603
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
Moake JL; Chow TW
Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664
[TBL] [Abstract][Full Text] [Related]
9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
Furlan M; Lämmle B
Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
[TBL] [Abstract][Full Text] [Related]
10. Platelet reactive conformation and multimeric pattern of von Willebrand factor in acquired thrombotic thrombocytopenic purpura during acute disease and remission.
Lotta LA; Lombardi R; Mariani M; Lancellotti S; De Cristofaro R; Hollestelle MJ; Canciani MT; Mannucci PM; Peyvandi F
J Thromb Haemost; 2011 Sep; 9(9):1744-51. PubMed ID: 21726405
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the role of von Willebrand factor in thrombotic thrombocytopenic purpura.
Lian EC; Siddiqui FA
Blood; 1985 Nov; 66(5):1219-21. PubMed ID: 3876857
[TBL] [Abstract][Full Text] [Related]
13. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation.
Jy W; Jimenez JJ; Mauro LM; Horstman LL; Cheng P; Ahn ER; Bidot CJ; Ahn YS
J Thromb Haemost; 2005 Jun; 3(6):1301-8. PubMed ID: 15946221
[TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.
Karpman D; Lethagen S; Kristoffersson A; Isaksson C; Holmberg L
Thromb Haemost; 1997 Dec; 78(6):1456-62. PubMed ID: 9423794
[TBL] [Abstract][Full Text] [Related]
15. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
[TBL] [Abstract][Full Text] [Related]
16. The changing paradigm of thrombotic thrombocytopenic purpura.
Raife TJ
Semin Thromb Hemost; 2005 Dec; 31(6):641-51. PubMed ID: 16388415
[TBL] [Abstract][Full Text] [Related]
17. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura.
Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B
Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339
[TBL] [Abstract][Full Text] [Related]
18. A novel nanobody that detects the gain-of-function phenotype of von Willebrand factor in ADAMTS13 deficiency and von Willebrand disease type 2B.
Hulstein JJ; de Groot PG; Silence K; Veyradier A; Fijnheer R; Lenting PJ
Blood; 2005 Nov; 106(9):3035-42. PubMed ID: 16014562
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocetin-induced platelet aggregation.
Yoo G; Blombäck M; Schenck-Gustafsson K; He S
Br J Haematol; 2003 Apr; 121(1):123-9. PubMed ID: 12670342
[TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
